The ulrich medical Group’s strategy of increasingly positioning itself internationally has also paid off in 2025: With sales growth of 10 percent, ulrich medical significantly exceeds the average of the German medical technology industry. According to the BVMed Autumn Survey 2025*, the weighted sales growth of the branch was only 3.1 percent domestically and 5.5 percent worldwide.
Several growth drivers lead to a good result
The US market was one of the key growth engines in 2025. In addition, in the spinal surgery product division, the uCentum Pro screw-rod system was successfully launched last year, which drove growth in Germany and Europe. The strong growth in the Radiology product division confirms the focus on customer needs and service combined with the advantages of ulrich medical technology in the Contrast Media Injectors sector. ulrich medical is taking this into account by investing in new capacities: Production for the product division Contrast Media Injectors has already been underway on 1,200 square meters of newly rented space in Dornstadt, near Ulm, since the end of May 2025. New production capacities for radiology are also currently being created at the Jungingen site.
Looking ahead with confidence
Friedrich von Rechteren, CEO and Chairman of the Management Board, classifies the result and looks ahead with confidence: “Our strong focus on the needs of our customers and the flexibility to adapt to changing market requirements has resulted in above-average growth rates for our company. For the current year, we also expect above-average growth – both in product division spine and in radiology, despite difficult global and national conditions.”
Further information can be found at https://www.ulrichmedical.com/en
*Source: Situation of the branch: Results of the Autumn Survey 2025 of the German Medical Technology Association (BVMed): https://www.bvmed.de/branche/lage/ergebnisse-der-bvmed-herbstumfrage-2025 (accessed on 20.04.2026).
About ulrich medical
The ulrich medical group consists of the mother company ulrich GmbH & Co. KG and its subsidiaries in France, Spain and the USA. The internationally operating group develops, produces and distributes products for spinal surgery and radiology under the ulrich medical brand. Founded in 1912, the family-owned company employs over 680 people worldwide. While the products are used worldwide, the medical technology company focuses on quality “Made in Germany”, where the majority of development and production takes place. An additional development site in the USA strengthens the group’s international positioning and creates the conditions for the successful positioning of our innovative solutions. ulrich medical increased its sales again in 2025 – for the 16th year in a row – and this sustained growth underlines its position as a reliable partner in the medical technology industry. In 2025, the company was honored with the German Brand Award and the Ulm Marketing Prize for its excellent brand strategy.